# Use of Bivalirudin for Anticoagulation in Patients With Extracorporeal Membrane Oxygenation

> **NCT06275555** · NA · RECRUITING · sponsor: **Xiaotong Hou** · enrollment: 154 (estimated)

## Conditions studied

- Extracorporeal Membrane Oxygenation Complication

## Interventions

- **DRUG:** bivalirudin
- **DRUG:** unfractionated heparin

## Key facts

- **NCT ID:** NCT06275555
- **Lead sponsor:** Xiaotong Hou
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-03
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-03-01
- **Target enrollment:** 154 (ESTIMATED)
- **Last updated:** 2026-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06275555

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06275555, "Use of Bivalirudin for Anticoagulation in Patients With Extracorporeal Membrane Oxygenation". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06275555. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*